Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$841000.0.

  • Journey Medical's Other Working Capital Changes rose 2774.91% to -$841000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $396000.0, marking a year-over-year increase of 2452.83%. This contributed to the annual value of -$376000.0 for FY2024, which is 23476.7% down from last year.
  • Per Journey Medical's latest filing, its Other Working Capital Changes stood at -$841000.0 for Q3 2025, which was up 2774.91% from $84000.0 recorded in Q2 2025.
  • Journey Medical's 5-year Other Working Capital Changes high stood at $2.7 million for Q4 2023, and its period low was -$1.2 million during Q3 2024.
  • For the 5-year period, Journey Medical's Other Working Capital Changes averaged around -$1368.4, with its median value being -$478000.0 (2021).
  • In the last 5 years, Journey Medical's Other Working Capital Changes surged by 753548.39% in 2022 and then crashed by 83763.44% in 2023.
  • Over the past 5 years, Journey Medical's Other Working Capital Changes (Quarter) stood at $31000.0 in 2021, then surged by 7535.48% to $2.4 million in 2022, then rose by 12.55% to $2.7 million in 2023, then fell by 26.05% to $2.0 million in 2024, then plummeted by 142.69% to -$841000.0 in 2025.
  • Its Other Working Capital Changes stands at -$841000.0 for Q3 2025, versus $84000.0 for Q2 2025 and -$817000.0 for Q1 2025.